About UsNewsShop
Fighting hereditary breast and ovarian cancer
Information & Research
| More

PARP Inhibitor Breast Cancer Trials By State

 

PARP Inhibitor Breast Cancer Clinical Trials Listed by State

The below studies are PARP Inhibitor studies that are currently enrolling patients with breast cancer listed by state. For more details on an individual study, please contact the study coordinator or visit clinicaltrials.gov.

Arizona

California

Colorado

District of Columbia

Florida

Georgia

NCT01042379: I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Illinois

Indiana

Kansas

Maryland

Massachusetts

Michigan

Minnesota

Nebraska

New Jersey

New Mexico

New York

North Carolina

Ohio

Oregon

Pennsylvania

Tennessee

Texas

Virginia

Washington

 


Page updated 01/10/12

Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.

Privacy Policy | Sitemap | Contact Us

Morphtek

This site has been made possible by a generous grant from Morphotek.


Web design by Rareheron Web Design

copyright © FORCE: Facing Our Risk of Cancer Empowered, Inc.  •  info@facingourrisk.org